MDCO Average Annual Return 10 Years
MDCO Average Annual Return Chart 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into MDCO

Also see:
• MDCO stock yearly return 2011
• MDCO stock yearly return 2012
• MDCO stock yearly return 2013
• MDCO stock yearly return 2014
• MDCO stock yearly return 2015
• MDCO stock yearly return 2016
• MDCO stock yearly return 2017
• MDCO stock yearly return 2018
• MDCO stock yearly return 2019
• MDCO stock yearly return 2020
• MDCO YTD return
Average Annual Return Benchmarks
Compare MDCO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
MDCO Share Performance
MDCO Average Annual Return Table 10 Years
Start date: 09/14/2011
End date: 01/06/2020
Start price/share: $15.07
End price/share: $84.90
Dividends collected/share: $0.00
Total return: 463.37%
Average Annual Total Return: 23.10%
Starting investment: $10,000.00
Ending investment: $56,331.22
Years: 8.32


MDCO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Medicines Co (The)
Medicines is a biopharmaceutical company. Co. is focused on inclisiran, the investigational RNA interference therapeutic, that inhibits production of proprotein convertase subtilisin/kexin type 9, a main protein that controls low-density lipoprotein-cholesterol levels. Co. has the right to develop, manufacture and commercialize inclisiran under its collaboration agreement with Alnylam Pharmaceuticals, Inc. The MDCO average annual return 10 years is shown above.

The Average Annual Return on the MDCO average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether MDCO average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the MDCO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
MDCO Current Stock Quote
Quotes delayed 20 minutes
Get Free SEC filing alerts for MDCO:
MDCO SEC Filing Email Alerts ServiceExternal link
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Average Annual Return Peers
MDCO (MDCO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

MDGL Average Annual Return
MDT Average Annual Return
MDXG Average Annual Return
MEIP Average Annual Return
MGEN Average Annual Return
MGLN Average Annual Return
MGNX Average Annual Return
MLNT Average Annual Return
MMM Average Annual Return
MMSI Average Annual Return
More Healthcare companies »

 

MDCO Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.